Market Overview

UPDATE: JP Morgan Initiates Cerner at Overweight on Leadership, Outlook

Share:
Related CERN
Benzinga's Top Upgrades
Barron's Picks And Pans: Interpublic, Zimmer Biomet And More

JP Morgan initiated coverage on Cerner (NASDAQ: CERN) with an Overweighr rating and a $93 price target

JP Morgan commented, "In the large hospital market (>200 beds), Cerner has ~21% market share of clinical systems, just behind privately-held Epic. Cerner has been gaining share in recent years, improving from just 15% market share in 2005, while competitors have been losing ground. The top 3 clinical system vendors account for 65% of the market, yet we believe dissatisfaction with other large vendors should create opportunities for market share gains for Cerner."

Cerner closed at $80.45 on Wednesday.

Latest Ratings for CERN

DateFirmActionFromTo
Jun 2016SunTrust Robinson HumphreyUpgradesNeutralBuy
Feb 2016Goldman SachsDowngradesBuyNeutral
Feb 2016Evercore ISI GroupDowngradesBuyHold

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CERN)

View Comments and Join the Discussion!